The global enteral feeding devices market size is estimated to reach USD 5.94 billion by 2030, expanding at a CAGR of 5.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. According to an NCBI article published in 2018, the prevalence of nutrient deficiency in the geriatric population is nearly 15% in ambulatory outpatients, 35-65% among hospitalized patients, and 20-60% in institutionalized patients. Thus, healthcare professionals are maximizing options for enteral nutrition among the elderly, which is expected to boost the market.
In addition, aging weakens the immune system, increasing the patient’s susceptibility to infectious diseases and affecting crucial body functions. Myelodysplastic syndromes are disorders that occur due to low blood count, wherein bone marrow produces very few functioning and/or mature RBCs. This increases the risk of infection and anemia-related problems, thereby boosting the demand for enteral feeding devices.
Increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the enteral feeding devices industry. Obesity is a major factor leading to diabetes. According to the WHO, in 2021, an estimated 39% of adults aged 18 years and over were overweight, and 13% were obese globally. In addition to obesity, diabetes is becoming increasingly prevalent globally. The International Diabetes Federation (IDF) estimated 537 million adults (aged 20-79 years) living with diabetes in 2021, and this number is expected to rise to 643 million by 2030.
IDF also reports that the prevalence of diabetes is increasing globally, with the highest increments witnessed in low- and middle-income countries. Diabetic neuropathy is another condition where the nutritional requirements of patients with damage to the nerve and blood vessels are managed through medical foods. According to an article published in ScienceDirect in July 2021, the prevalence of peripheral neuropathy was high among diabetic patients, accounting for around 40.3%, and type 2 diabetic patients are more susceptible to it than type 1 diabetic patients. The risk of neuropathy significantly increases with age, changes in diet, and unhealthy lifestyles. Enteral nutrition can help relieve symptoms or slow down the progression of a chronic condition.
Enteral feeding product companies have started offering a broad portfolio of ready-to-use oral nutritional supplements, tube feeds, and powder products in recent times. Rapid technological advancements that help offer texture-modified products to meet the individual needs of different patients related to portable pumps, disposable sets, stationary pumps, and accessories for enhanced accuracy, portability, and cost-effectiveness are expected to be high-impact rendering drivers for this market.
In September 2018, the U.S. FDA issued a letter to enteral feeding device manufacturers, healthcare professionals, distributors, and the department of purchasing in hospitals with the subject line—The FDA Encourages Use of Enteral Device Connectors that Reduce Risk of Misconnection and Patient Injury. This indicates increasing intervention by governing bodies to boost usage by healthcare professionals. Therefore, it is expected to drive market growth over the forecast period.
Request a free sample copy or view report summary: Enteral Feeding Devices Market Report
Based on products, enteral feeding pumps dominated the market in 2024 with a 50.8% share. Enteral feeding is common across pediatric and adult populations diagnosed with chronic diseases to increase nutritional intake & prevent malnutrition
Based on age group, the adult age group segment dominated the market with the largest revenue share in 2024. Growing demand for enteral nutrition formulations in the adult population is one of the crucial factors anticipated to boost the market in the coming years
Cancer weakens immunity and leads to loss of energy, which results in malnutrition in 40-80% of the cases. This affects the response to treatment as well as increases treatment-related toxicity. Hence, to maintain nutrition and positive nitrogen balance in the body, tube feeding is used
Based on end-use, hospitals dominated the market in 2024. Growing awareness among healthcare professionals and others regarding hospital-associated malnutrition is one of the significant factors expected to boost the use and demand for enteral feeding devices in hospitals.
In March 2023, Gravitas Medical recently received FDA 510(k) clearance for its Enteric feeding tube system. It features a "smart" nasogastric tube equipped with sensors to track the tube's position and monitor during feeding.
Grand View Research has segmented the global enteral feeding devices market based on product, age group, indication, end use, and region:
Enteral Feeding Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Giving Sets
Enteral Feeding Pumps
Enteral Feeding tubes
Nasogastric Tube
Gastrostomy Tube
Others
Enteral Feeding Bags
Percutaneous Endoscopic Gastrostomy Device
Low Profile Gastrostomy Device
Other Accessories
Enteral Feeding Devices Age Group Outlook (Revenue, USD Million, 2018 - 2030)
Adults
Pediatrics
Enteral Feeding Devices Indication Outlook (Revenue, USD Million, 2018 - 2030)
Alzheimer’s
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
Enteral Feeding Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Home Care
Enteral Feeding Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Enteral Feeding Devices Market
Conmed Corporation
C.R.Bard
Gravitas Medical
Cook Medical
Boston Scientific Corporation
Moog Inc.
Fresenius Kabi AG
Danone Medical Nutrition
Kimberly-Clark
Abbott Nutrition
B Braun Melsungen AG
Avanos Medical, Inc.
Cardinal Health
Applied Medical Technology, Inc.
Vygon India
Fidmi Medical
ALCOR Scientific
Amsino International, Inc.
"The quality of research they have done for us has been excellent..."